Elham Hedayati

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: CARDIO-ONCOLOGY. 2025;11(1):56
Use of anthracyclines and trastuzumab for breast cancer in women with and without a history of cardiovascular disease in Sweden: a national cross-sectional study
Carreira H; Strongman H; Feychting M; Hubbert L; Hedayati E; Bidulka P; Matthews A; Bhaskaran K
Article: CARDIO-ONCOLOGY. 2025;11(1):5
Cardiovascular health in breast cancer patients: insight on BRCA1/2 mutations impact
Mallios P; Manshadi MD; Hubbert L; Aydin T; Maes C; Rantala J; Liljegren A; Kiani NA; Hedayati E
Article: LANCET REGIONAL HEALTH-EUROPE. 2024;42:100925
Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study)
Stenmarker M; Mallios P; Hedayati E; Rodriguez-Wallberg KA; Johnsson A; Alfredsson J; Ekman B; Legert KG; Borland M; Mellergard J; Eriksson M; Marteinsdottir I; Davidson T; Engerstrom L; Sandsveden M; Keskisaerkkae R; Singull M; Hubbert L
Article: CANCERS. 2024;16(4):738
Subtype-Specific Survival of Young Women with Breast Cancer and Its Interaction with the Germline BRCA Status
Hage AM; Gebert P; Blohmer J-U; Hedayati E; Speiser D; Karsten MM
Article: PALLIATIVE CARE AND SOCIAL PRACTICE. 2024;18:26323524231225249
Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project
Rietjens JAC; Griffioen I; Sierra-Perez J; Sroczynski G; Siebert U; Buyx A; Peric B; Svane IM; Brands JBP; Steffensen KD; Piqueras CR; Hedayati E; Karsten MM; Couespel N; Akoglu C; Pazo-Cid R; Rayson P; Lingsma HF; Schermer MHN; Steyerberg EW; Payne SA; Korfage IJ; Stiggelbout AM
Article: EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. 2023;12(8):495-503
Poorer survival after out-of-hospital cardiac arrest among cancer patients: a population-based register study
Hagglund HL; Jonsson M; Hedayati E; Hedman C; Djarv T
Article: BREAST. 2023;70:18-24
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study
Thurell J; Manouchehri N; Fredriksson I; Wilking U; Bergh J; Ryden L; Koppert LB; Karsten MM; Kiani NA; Hedayati E
Article: JAMA NETWORK OPEN. 2023;6(7):e2323752
Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer
He W; Zeng E; Sjolander A; Hubbert L; Hedayati E; Czene K
Article: CANCER MEDICINE. 2023;12(9):10840-10850
Planning for return to work during the first year after breast cancer metastasis: A Swedish cohort study
Johnsson A; Kiani NA; Gernaat SAM; Wilking U; Shabo I; Hedayati E
Article: BREAST CANCER RESEARCH AND TREATMENT. 2023;198(2):265-281
International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients
de Ligt KM; de Rooij BH; Hedayati E; Karsten MM; Smaardijk VR; Velting M; Saunders C; Travado L; Cardoso F; Lopez E; Carney N; Wengstrom Y; Ives A; Velikova G; Sousa Fialho MDL; Seidler Y; Stamm TA; Koppert LB; van de Poll-franse LV
Article: PLOS ONE. 2023;18(3):e0283003
GATA-3 expression in breast cancer is related to intratumoral M2 macrophage infiltration and tumor differentiation
Oda H; Hedayati E; Lindstrom A; Shabo I
Article: FRONTIERS IN ONCOLOGY. 2023;13:1095251
Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study
Hubbert L; Mallios P; Karlstrom P; Papakonstantinou A; Bergh J; Hedayati E
Article: JAMA ONCOLOGY. 2022;8(10):1438-1446
Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis
Marklund A; Lekberg T; Hedayati E; Liljegren A; Bergh J; Lundberg FE; Rodriguez-Wallberg KA
Article: EUROPEAN JOURNAL OF CANCER CARE. 2022;31(5):e13626
Use of sickness benefits by patients with metastatic breast cancer-A Swedish cohort study
Altena R; Gernaat SAM; Wilking U; Kiani NA; Johnsson A; Hedayati E
Article: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. 2022;50(4):3000605221093179
How COVID-19 changed clinical research strategies: a global survey
Bauer A; Eskat A; Ntekim A; Wong C; Eberle D; Hedayati E; Tay F; Yau H; Stockley L; Redondo MDM; Sen S; Egert-Schwender S; Uresin Y; Grossmann R
Article: ELIFE. 2022;11:e71562
Risk of heart disease following treatment for breast cancer - results from a population-based cohort study
Yang H; Bhoo-Pathy N; Brand JS; Hedayati E; Grassmann F; Zeng E; Bergh J; Bian W; Ludvigsson JF; Hall P; Czene K
Article: SCIENTIFIC REPORTS. 2022;12(1):1643
Preliminary results using a kit to measure tamoxifen and metabolites concentrations in capillary blood samples from women with breast cancer
Rehnmark S; Shabo I; Randahl H; Wengstrom Y; Rydberg P; Hedayati E
Article: SCIENTIFIC REPORTS. 2021;11(1):2707
Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study
Gernaat SAM; von Stedingk H; Hassan M; Nilsson HP; Rodriguez-Wallberg KA; Hedayati E; Rydberg P
Article: JAMA ONCOLOGY. 2021;7(1):86-91
Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation
Marklund A; Lundberg FE; Eloranta S; Hedayati E; Pettersson K; Rodriguez-Wallberg KA
Article: EUROPEAN JOURNAL OF CANCER CARE. 2021;30(1):e13353
Sickness absence and disability pension among swedish women prior to breast cancer relapse with a special focus on the roles of treatment and comorbidity
Gernaat SAM; Johnsson A; Altena R; Wilking U; Hedayati E
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2020;6(2):147-155
Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study
Hedayati E; Papakonstantinou A; Gernaat SAM; Altena R; Brand JS; Alfredsson J; Bhoo-Pathy N; Herrmann J; Linde C; Dahlstrom U; Bergh J; Hubbert L
Article: CANCER. 2020;126(6):1175-1182
Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial
Papakonstantinou A; Matikas A; Bengtsson NO; Malmstrom P; Hedayati E; Steger G; Untch M; Hubbert L; Johansson H; Hellstrom M; Gnant M; Loibl S; Greil R; Moebus V; Foukakis T; Bergh J
Article: ACTA ONCOLOGICA. 2020;59(1):75-81
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer
Papakonstantinou A; Hedayati E; Hellstrom M; Johansson H; Gnant M; Steger G; Greil R; Untch M; Moebus V; Loibl S; Foukakis T; Bergh J; Matikas A
Article: CARDIO-ONCOLOGY. 2020;6(1):16
Approaches to management of cardiovascular morbidity in adult cancer patients - cross-sectional survey among cardio-oncology experts
Hedayati E; Papakonstantinou A; Mansson-Broberg A; Bergh J; Hubbert L; Altena R
Article: VIRCHOWS ARCHIV. 2019;475(2):151-162
Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery
Garvin S; Patil EV; Arnesson L-G; Oda H; Hedayati E; Lindstrom A; Shabo I
Article: PLOS ONE. 2019;14(2):e0211783
Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden
Hedayati E; Fracheboud L; Srikant V; Greber D; Wallberg S; Stragliotto CL
Article: CANCER. 2017;123(3):468-475
Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.
Brand JS; Hedayati E; Bhoo-Pathy N; Bergh J; Hall P; Humphreys K; Ludvigsson JF; Czene K
Article: CLINICAL CANCER RESEARCH. 2016;22(21):5249-5255
Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients.
Brand JS; Hedayati E; Humphreys K; Ludvigsson JF; Johansson ALV; Bergh J; Hall P; Czene K
Article: LANCET. 2015;386(9992):433-443
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Gnant M; Pfeiler G; Dubsky PC; Hubalek M; Greil R; Jakesz R; Wette V; Balic M; Haslbauer F; Melbinger E; Bjelic-Radisic V; Artner-Matuschek S; Fitzal F; Marth C; Sevelda P; Mlineritsch B; Steger GG; Manfreda D; Exner R; Egle D; Bergh J; Kainberger F; Talbot S; Warner D; Fesl C; Singer CF
Article: MOLECULAR ONCOLOGY. 2015;9(7):1384-1391
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer
Foukakis T; Lovrot J; Sandqvist P; Xie H; Lindstrom LS; Giorgetti C; Jacobsson H; Hedayati E; Bergh J
Article: ASAIO JOURNAL. 2014;60(6):e3-e4
Young Woman With Breast Cancer and Cardiotoxicity With Severe Heart Failure Treated With a HeartMate II™ for Nearly 6 Years Before Heart Transplantation
Sundbom P; Hedayati E; Peterzen B; Granfeldt H; Ahn H; Hubbert L
Article: SCANDINAVIAN JOURNAL OF CARING SCIENCES. 2013;27(2):380-387
Cognitive, psychosocial, somatic and treatment factors predicting return to work after breast cancer treatment
Hedayati E; Johnsson A; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2012;16(3):315-322
Effects of adjuvant treatment on cognitive function in women with early breast cancer
Hedayati E; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
Article: ACTA ONCOLOGICA. 2011;50(7):1027-1036
The effects of breast cancer diagnosis and surgery on cognitive functions
Hedayati E; Schedin A; Nyman H; Alinaghizadeh H; Albertsson M
Visa fler

Alla övriga publikationer

Review: CANCERS. 2023;15(22):5440
Lung Carcinoids: A Comprehensive Review for Clinicians
Granberg D; Juhlin CC; Falhammar H; Hedayati E
Review: CARDIO-ONCOLOGY. 2021;7(1):20
Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer
Altena R; Hubbert L; Kiani NA; Wengstrom Y; Bergh J; Hedayati E
Review: CANCERS. 2021;13(10):2308
Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach
Clarijs ME; Thurell J; Kuehn F; Uyl-de Groot CA; Hedayati E; Karsten MM; Jager A; Koppert LB
Review: CURRENT HEART FAILURE REPORTS. 2020;17(6):397-408
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
Broberg AM; Geisler J; Tuohinen S; Skytta T; Hrafnkelsdottir PJ; Nielsen KM; Hedayati E; Omland T; Offersen BV; Lyon AR; Gulati G
Review: LAKARTIDNINGEN. 2016;113:DYIE
[Cardiotoxicity relatively common in cancer treatment].
Bühlmann Lerjen E; Hübbert L; Papakonstantinou A; Hedayati E; Linde C; Månsson Broberg A
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2015;51:S177-S178
Fast track introduction of subcutaneous trastuzumab
Hedayati E; Fuentes S; Iiristo M
Meeting abstract: CANCER RESEARCH. 2015;75:p5-21-07-p5-21-07
Unexpected low incidence of cardiovascular related events in women with primary breast cancer; population derived retrospective cohort
Papakonstantinou A; Hubbert L; Mikiver R; Bergh J; Hedayati E
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(15):e22120
Sequential metastatic biopsies and functional imaging in breast cancer
Foukakis T; Lovrot J; Sandqvist P; Xie H; Lindstroem LS; Giorgetti C; Jacobsson H; Hedayati E; Bergh JCS
Doctoral thesis: 2012
The effects of breast cancer treatment on cognitive functions
Hedayati E
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2008;26(15):11531
The effects of breast cancer treatment on cognitive functions
Hedayati E; Schedin A; Nyman H; Albertsson M; Nilsson BI
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2008;6(7):198
The effects of breast cancer treatment on cognitive functions
Hedayati E; Schedin A; Albertsson M; Nyman H; Nilsson B

Forskningsbidrag

Hedayati, Elham – Surviving Cancer, But at What Cost? Predicting Cardiovascular Risk in Breast and Childhood Cancer Survivors (RADAR-study); A Swedish Retrospective Study
Swedish Cancer Society
1 January 2024

Anställningar

Adjungerad Lektor, Onkologi-Patologi, Karolinska Institutet, 2023-2026
Adjungerad Lektor, Onkologi-Patologi, Karolinska Institutet, 2023-2025

Examina och utbildning

Docent, onkologi, Karolinska Institutet, 2022
Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2012

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI